Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2019

28.01.2019 | Original Article

Follow-up blood cultures add little value in the management of bacteremic urinary tract infections

verfasst von: HyeJin Shi, Cheol-In Kang, Sun Young Cho, Kyungmin Huh, Doo Ryeon Chung, Kyong Ran Peck

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The need for mandatory confirmation of negative conversion in bacteremic urinary tract infection (UTI) has not been adequately addressed, even though follow-up blood cultures (FUBCs) are still prescribed liberally. The purpose of this study was to identify possible risk factors associated with positive FUBCs. We retrospectively collected data on adult cases of bacteremic UTI with at least one FUBC. Patients were divided into the negative FUBCs and the positive FUBC group, and data of both groups were compared. Of 306 cases of bacteremic UTI, 251 had a negative result from an FUBC and 55 had a positive result. Diabetes mellitus, malignancy, complicated UTI, and initial intensive care unit (ICU) admission were significantly more common in the positive FUBC group than in the negative group (all-P < 0.05). Time to defervescence was significantly longer in the positive FUBC group than in the negative group (52.2 h vs. 25.3 h, P < 0.05). A multivariate analysis showed that malignancy, initial ICU admission, CRP > 16 (mg/dL), and a time to defervescence of more than 48 h were significant factors associated with a positive FUBC. No subsequent cases of bacteremia developed in patients without risk factors associated with a positive FUBC. In bacteremic UTIs, patients with positive FUBCs usually present with higher initial inflammatory markers, longer time to defervescence, more frequent ICU admission rates, and an elevated chance of having cancer. More careful clinical assessment before drawing FUBCs would reduce costs and inconvenience to patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13(169):1–38 Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13(169):1–38
7.
Zurück zum Zitat Bates DW, Cook EF, Goldman L, Lee TH (1990) Predicting bacteremia in hospitalized patients. A prospectively validated model Ann Intern Med 113(7):495–500CrossRefPubMed Bates DW, Cook EF, Goldman L, Lee TH (1990) Predicting bacteremia in hospitalized patients. A prospectively validated model Ann Intern Med 113(7):495–500CrossRefPubMed
10.
Zurück zum Zitat Wayne P (2007) Clinical and Laboratory Standards Institute: Principles and procedures for blood cultures; approved guideline Wayne P (2007) Clinical and Laboratory Standards Institute: Principles and procedures for blood cultures; approved guideline
11.
Zurück zum Zitat Bates DW, Goldman L, Lee TH (1991) Contaminant blood cultures and resource utilization. The true consequences of false-positive results. Jama 265(3):365–369CrossRefPubMed Bates DW, Goldman L, Lee TH (1991) Contaminant blood cultures and resource utilization. The true consequences of false-positive results. Jama 265(3):365–369CrossRefPubMed
13.
Zurück zum Zitat Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M (2018) Comparison between non-septic and septic cases in stone-related obstructive acute pyelonephritis and risk factors for septic shock: a multi-center retrospective study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. https://doi.org/10.1016/j.jiac.2018.08.002 Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M (2018) Comparison between non-septic and septic cases in stone-related obstructive acute pyelonephritis and risk factors for septic shock: a multi-center retrospective study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. https://​doi.​org/​10.​1016/​j.​jiac.​2018.​08.​002
14.
Zurück zum Zitat Archer A, Campbell A, D'Amato C, McLeod M, Rugg D (2016) Putting the ICD-10-CM/PCS GEMs into practice (updated). Journal of AHIMA 87(1):48–53PubMed Archer A, Campbell A, D'Amato C, McLeod M, Rugg D (2016) Putting the ICD-10-CM/PCS GEMs into practice (updated). Journal of AHIMA 87(1):48–53PubMed
16.
Zurück zum Zitat Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50(5):625–663CrossRefPubMed Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50(5):625–663CrossRefPubMed
17.
Zurück zum Zitat Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK (2018) Molecular beta-lactamase characterization of gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: efficacies analysed against susceptible and resistant subsets. Int J Antimicrob Agents 52(2):287–292. https://doi.org/10.1016/j.ijantimicag.2018.04.001 CrossRefPubMed Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK (2018) Molecular beta-lactamase characterization of gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: efficacies analysed against susceptible and resistant subsets. Int J Antimicrob Agents 52(2):287–292. https://​doi.​org/​10.​1016/​j.​ijantimicag.​2018.​04.​001 CrossRefPubMed
18.
Zurück zum Zitat Wayne P (2018) Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing:M100.296 Wayne P (2018) Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing:M100.296
19.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120. https://doi.org/10.1093/cid/ciq257 CrossRefPubMed Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120. https://​doi.​org/​10.​1093/​cid/​ciq257 CrossRefPubMed
21.
Zurück zum Zitat Furuichi M, Miyairi I (2016) Risk factors for persistent bacteremia in infants with catheter-related bloodstream infection due to coagulase-negative staphylococcus in the neonatal intensive care unit. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 22(12):785–789. https://doi.org/10.1016/j.jiac.2016.08.011 CrossRef Furuichi M, Miyairi I (2016) Risk factors for persistent bacteremia in infants with catheter-related bloodstream infection due to coagulase-negative staphylococcus in the neonatal intensive care unit. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 22(12):785–789. https://​doi.​org/​10.​1016/​j.​jiac.​2016.​08.​011 CrossRef
Metadaten
Titel
Follow-up blood cultures add little value in the management of bacteremic urinary tract infections
verfasst von
HyeJin Shi
Cheol-In Kang
Sun Young Cho
Kyungmin Huh
Doo Ryeon Chung
Kyong Ran Peck
Publikationsdatum
28.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03484-4

Weitere Artikel der Ausgabe 4/2019

European Journal of Clinical Microbiology & Infectious Diseases 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.